Companies › XCUR

Exicure Inc (XCUR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001698530 · EDGAR filings · Updated 2026-07-17

Exicure Inc (XCUR) has reported institutional ownership of 2.5%, with 18 institutional managers holding positions valued at $687.0K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-17 — SCHEDULE 13D/A filed
• 2026-06-30 — Current report (8-K) filed
• 2026-06-01 — Current report (8-K) filed
• 2026-05-29 — Quarterly report (10-Q) filed
• 2026-05-15 — Late-filing notice for quarterly report (NT 10-Q)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Exicure Inc has 18 institutional holders and institutional ownership of 2.5%.

Insider activity

Insiders reported 8 transactions (0 buys, 4 sells) across 3 reporting insiders, with a net reported value of −$11.6M.

Data flags from SEC filings

Related companies

INTELLIGENT BIO SOLUTIONS IN (INBS) · GENENTA SCIENCE S P A (GNTA) · BONE BIOLOGICS CORP (BBLG) · P3 HEALTH PARTNERS INC (PIII) · Kiora Pharmaceuticals Inc (KPRX) · GT BIOPHARMA INC (GTBP)